Table 1.
Concentration (mg/L) | 24 h mortality (%) | 48 h mortality (%) | 72 h mortality (%) |
Chlorantraniliprole | |||
0.0 | 0.0±0.0d | 0.0±0.0e | 0.0±0.0b |
3.3 | 0.0±0.0d | 0.0±0.0e | 10.0±10.0b |
4.0 | 10.0±10.0cd | 23.3±5.8d | 23.3±5.8b |
4.8 | 23.3±15.3c | 36.7±5.8c | 53.3±20.8a |
5.8 | 60.0±10.0b | 76.7±5.8b | 76.7±5.8a |
6.9 | 93.3±5.8a | 100.0±0.0a | |
8.3 | 100.0±0.0a | ||
One-way ANOVA | F6, 14=84.119 | F5, 12=303.533 | F4, 10=25.194 |
Flubendiamide-abamectin | |||
0.000 | 0.0±0.0d | 0.0±0.0d | 0.0±0.0b |
0.013 | 0.0±0.0d | 0.0±0.0d | 6.7±5.8b |
0.019 | 23.3±5.8c | 36.7±5.8c | 60.0±20.0a |
0.029 | 36.7±5.8c | 53.3±5.8b | 70.0±17.3a |
0.044 | 56.7±15.3b | 90.0±10.0a | 95.0±7.1a |
0.066 | 83.3±5.8a | 100.0±0.0a | |
0.100 | 100.0±0.0a | ||
One-way ANOVA | F6, 14=96.467 | F5, 12=199.200 | F4, 9=26.657 |
Penoxsulam | |||
0.0 | 0.0±0.0c | 0.0±0.0d | 0.0±0.0d |
0.8 | 0.0±0.0c | 0.0±0.0d | 0.0±0.0d |
1.0 | 13.3±5.8bc | 23.3±5.8c | 23.3±5.8c |
1.3 | 23.3±5.8bc | 46.7±15.3b | 60.0±0.0b |
1.6 | 30.0±0.0b | 50.0±0.0ab | 67.7±5.8b |
2.0 | 46.7±32.1b | 70.0±10.0a | 93.3±5.8a |
2.5 | 100.0±0.0a | ||
One-way ANOVA | F6, 14=23.222 | F5, 12=40.309 | F5, 12=241.333 |
*P < 0.001; Types with different superscripts differ significantly (Tukey's test, α=0.05, a > b > c > d > e); NS: not significant.